Helicobacter pylori eradication. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Control group will receive a regimen including pantoprazole tablets 40 mg two times per day, amoxicillin 1 g capsule two times per day, clarithromycin 500 mg capsules two times per day
Placebo
Treatment - Drugs
Control group will receive a regimen including pantoprazole tablets 40 mg two times per day, amoxicillin 1 g capsule two times per day, clarithromycin 500 mg capsules two times per day and a placebo w
Intervention group will receive a regimen including pantoprazole tablets 40 mg two times per day, amoxicillin 1 g capsule two times per day, clarithromycin 500 mg capsules two times per day and thyme
Sponsors
Vice Chancellor for Research of Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Positive result for urea breath test Exclusion criteria: Receiving of Helicobacter pylori eradication therapy during past six months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Negative urea breath test. Timepoint: Six weeks after initiation of interventions. Method of measurement: Urea breath test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori infection. Timepoint: Six weeks after interventions. Method of measurement: Urea breath test. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed